SQI Diagnostics, a company that develops and manufactures respiratory health and precision medicine tests, extended the maturity date of its credit agreement with Pivot Financial dated Feb. 8, 2022, to Oct. 11, 2022. All of the other terms of the credit agreement remain unchanged.
Kane Biotech further amended its credit agreement with Pivot Financial. The amendment extended the maturity to Jan. 31, 2023, and increased the credit facility to $4 million, with approximately $1.8 million of new capital having been provided.
Kane Biotech entered into an amended and restated credit agreement with Pivot Financial, increasing the credit facility to $2.5 million from $1.48 million.
Asset manager Pivot Financial entered into a one-year credit agreement with biotech company Kane Biotech, providing the company with a $1.48 million non-revolving term loan.
GreenSpace Brands has entered a new credit facility with Pivot Financial to replace its previous ABL facility. The structure and conditions of the new debt facility include a $3.5 million term loan and a $4.0 million full recourse accounts receivable factoring facility.